TELA Bio, Inc. (TELA) Earnings History
Annual and quarterly earnings data from 2017 to 2024
Loading earnings history...
TELA EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
TELA Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | 67.1% | -49.2% | -54.6% |
| 2023 | 68.6% | -75.4% | -79.8% |
| 2022 | 65.3% | -94.2% | -106.9% |
| 2021 | 63.9% | -100.0% | -112.9% |
| 2020 | 61.7% | -138.8% | -158.1% |
Download Data
Export TELA earnings history in CSV or JSON format
Free sign-in required to download data
TELA Bio, Inc. (TELA) Earnings Overview
As of May 8, 2026, TELA Bio, Inc. (TELA) reported trailing twelve-month net income of -$39M, reflecting +34.8% year-over-year growth. The company earned $-0.86 per diluted share over the past four quarters, with a net profit margin of -54.6%.
Looking at the long-term picture, TELA's historical earnings data spans multiple years. The company achieved its highest annual net income of -$21M in fiscal 2018.
TELA Bio, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including XTNT ($2M net income, -14.0% margin), ATRC (-$5M net income, -2.1% margin), NVCR (-$173M net income, -20.8% margin), TELA has room to improve margins relative to the peer group. Compare TELA vs XTNT →
TELA Earnings vs Peers
Earnings metrics vs comparable public companies
TELA Historical Earnings Data (2017–2024)
8 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$38M | +18.9% | -$34M | $-1.33 | -54.6% | -49.2% |
| 2023 | -$47M | -5.3% | -$44M | $-2.04 | -79.8% | -75.4% |
| 2022 | -$44M | -33.1% | -$39M | $-2.73 | -106.9% | -94.2% |
| 2021 | -$33M | -15.6% | -$29M | $-2.30 | -112.9% | -100.0% |
| 2020 | -$29M | -28.4% | -$25M | $-2.23 | -158.1% | -138.8% |
| 2019 | -$22M | -6.3% | -$19M | $-2.26 | -145.2% | -124.1% |
| 2018 | -$21M | +1.1% | -$18M | $-3.25 | -254.9% | -214.9% |
| 2017 | -$21M | - | -$17M | $-3.29 | -502.6% | -398.7% |
See TELA's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs TELA Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare TELA vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonTELA — Frequently Asked Questions
Quick answers to the most common questions about buying TELA stock.
Is TELA growing earnings?
TELA EPS is $-0.86, with earnings growth accelerating to +34.8%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-39M.
What are TELA's profit margins?
TELA Bio, Inc. net margin is -54.6%, with operating margin at -49.2%. Below-average margins reflect competitive or cost pressures.
How consistent are TELA's earnings?
TELA earnings data spans 2017-2024. The accelerating earnings trend is +34.8% YoY. Historical data enables comparison across business cycles.